You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
MBS has developed a compact endpoint PCR system which can test more than 22,000 patient samples per day by performing eight-minute thermal cycling.
The kit is designed to detect the RdRP gene, E gene, and N gene of the virus and runs on all major thermocyclers.
The MBS NextGenPCR system was distributed by Canon Biomedical in the US until that firm ceased operations early last year.
The company is developing dedicated product lines for next-generation sequencing that incorporate a thermal cycler capable of 35-minute PCR.
Intas Science Imaging Instruments will launch the Dutch biotechnology company's NextGen PCR thermal cycler in the German market.
The newly independent firm will continue to invest in diagnostics by bringing its menu of PCR tests for infectious diseases to the US and other markets, among other objectives.
The exclusive deal includes sales and marketing of a rapid thermal cycler as well as consumable microplates and pipette tips.
Dutch firm Molecular Biology Systems announced new distribution pacts for its ultra-fast thermal cycler in seven countries or regions.
The firm has improved design of the system for low-resource settings and validated it on clinical chlamydia samples and extracted HIV, Ebola, and dengue samples.
The company will showcase the next generation of its Philisa platform, a real-time PCR system which can run four multiplexed qPCR protocols in about 20 minutes.
The World Health Organization will be providing low-cost COVID-19 tests to low- and middle-income nations, according to Reuters.
Nature News examines how the confirmation of Amy Coney Barrett to the US Supreme Court could affect scientific agencies.
Nobel Prize-winner Arthur Ashkin, who developed optical tweezers, has died at 98, the Washington Post reports.
In PNAS this week: altered gene expression in brain samples from Alzheimer's disease patients, effects of gene mutations found in bladder cancer, and more.